137 related articles for article (PubMed ID: 22829886)
21. Concerted changes in transcriptional regulation of genes involved in DNA methylation, demethylation, and folate-mediated one-carbon metabolism pathways in the NCI-60 cancer cell line panel in response to cancer drug treatment.
Krushkal J; Zhao Y; Hose C; Monks A; Doroshow JH; Simon R
Clin Epigenetics; 2016; 8():73. PubMed ID: 27347216
[TBL] [Abstract][Full Text] [Related]
22. Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents.
Namdar M; Perez G; Ngo L; Marks PA
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):20003-8. PubMed ID: 21037108
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model.
Miyanaga A; Gemma A; Noro R; Kataoka K; Matsuda K; Nara M; Okano T; Seike M; Yoshimura A; Kawakami A; Uesaka H; Nakae H; Kudoh S
Mol Cancer Ther; 2008 Jul; 7(7):1923-30. PubMed ID: 18606719
[TBL] [Abstract][Full Text] [Related]
24. HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.
Bruzzese F; Leone A; Rocco M; Carbone C; Piro G; Caraglia M; Di Gennaro E; Budillon A
J Cell Physiol; 2011 Sep; 226(9):2378-90. PubMed ID: 21660961
[TBL] [Abstract][Full Text] [Related]
25. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.
Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK
Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267
[TBL] [Abstract][Full Text] [Related]
26. Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells.
Mühlethaler-Mottet A; Meier R; Flahaut M; Bourloud KB; Nardou K; Joseph JM; Gross N
Mol Cancer; 2008 Jun; 7():55. PubMed ID: 18549473
[TBL] [Abstract][Full Text] [Related]
27. The mechanism of action of the histone deacetylase inhibitor vorinostat involves interaction with the insulin-like growth factor signaling pathway.
Sarfstein R; Bruchim I; Fishman A; Werner H
PLoS One; 2011; 6(9):e24468. PubMed ID: 21931726
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of tissue factor by siRNA increased doxorubicin-induced apoptosis in human neuroblastoma.
Fang J; Tang H; Xia L; Zhou M; Chen Y; Wei W; Hu Y; Song S; Hong M
J Huazhong Univ Sci Technolog Med Sci; 2008 Feb; 28(1):42-5. PubMed ID: 18278454
[TBL] [Abstract][Full Text] [Related]
29. Molecular cytogenetic characterization of doxorubicin-resistant neuroblastoma cell lines: evidence that acquired multidrug resistance results from a unique large amplification of the 7q21 region.
Flahaut M; Mühlethaler-Mottet A; Martinet D; Fattet S; Bourloud KB; Auderset K; Meier R; Schmutz NB; Delattre O; Joseph JM; Gross N
Genes Chromosomes Cancer; 2006 May; 45(5):495-508. PubMed ID: 16450357
[TBL] [Abstract][Full Text] [Related]
30. ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid.
Wu JC; Jiang HM; Yang XH; Zheng HC
Cancer Med; 2018 Sep; 7(9):4554-4569. PubMed ID: 30091530
[TBL] [Abstract][Full Text] [Related]
31. Artemether Regulates Chemosensitivity to Doxorubicin via Regulation of B7-H3 in Human Neuroblastoma Cells.
Tan WQ; Chen G; Ye M; Jia B
Med Sci Monit; 2017 Sep; 23():4252-4259. PubMed ID: 28866709
[TBL] [Abstract][Full Text] [Related]
32. Targeted polytherapy in small cell sarcoma and its association with doxorubicin.
Dumont SN; Yang D; Dumont AG; Reynoso D; Blay JY; Trent JC
Mol Oncol; 2014 Dec; 8(8):1458-68. PubMed ID: 24998445
[TBL] [Abstract][Full Text] [Related]
33. Alterations of ionic membrane permeabilities in multidrug-resistant neuroblastoma x glioma hybrid cells.
Gérard V; Rouzaire-Dubois B; Dilda P; Dubois JM
J Exp Biol; 1998 Jan; 201(Pt 1):21-31. PubMed ID: 9390933
[TBL] [Abstract][Full Text] [Related]
34. Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression.
Barbone D; Cheung P; Battula S; Busacca S; Gray SG; Longley DB; Bueno R; Sugarbaker DJ; Fennell DA; Broaddus VC
PLoS One; 2012; 7(12):e52753. PubMed ID: 23300762
[TBL] [Abstract][Full Text] [Related]
35. Redox-Mediated Suberoylanilide Hydroxamic Acid Sensitivity in Breast Cancer.
Chiaradonna F; Barozzi I; Miccolo C; Bucci G; Palorini R; Fornasari L; Botrugno OA; Pruneri G; Masullo M; Passafaro A; Galimberti VE; Fantin VR; Richon VM; Pece S; Viale G; Di Fiore PP; Draetta G; Pelicci PG; Minucci S; Chiocca S
Antioxid Redox Signal; 2015 Jul; 23(1):15-29. PubMed ID: 25897982
[TBL] [Abstract][Full Text] [Related]
36. Lipotropes enhance the anti-proliferative effect of chemotherapeutic drugs in MCF-7 human breast cancer cells.
Cho K; Mabasa L; Walters MW; Park CS
Oncol Rep; 2013 Jun; 29(6):2237-42. PubMed ID: 23588242
[TBL] [Abstract][Full Text] [Related]
37. Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed.
Di Gennaro E; Bruzzese F; Pepe S; Leone A; Delrio P; Subbarayan PR; Avallone A; Budillon A
Cancer Biol Ther; 2009 May; 8(9):782-91. PubMed ID: 19270508
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin.
Alshaer W; Alqudah DA; Wehaibi S; Abuarqoub D; Zihlif M; Hatmal MM; Awidi A
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357721
[TBL] [Abstract][Full Text] [Related]
39. Glycolysis inhibition and its effect in doxorubicin resistance in neuroblastoma.
Bean JF; Qiu YY; Yu S; Clark S; Chu F; Madonna MB
J Pediatr Surg; 2014 Jun; 49(6):981-4; discussion 984. PubMed ID: 24888847
[TBL] [Abstract][Full Text] [Related]
40. Targeting histone deacetylases: development of vorinostat for the treatment of cancer.
Richon VM
Epigenomics; 2010 Jun; 2(3):457-65. PubMed ID: 22121904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
